drugset / Trial / NCT01624116

Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes

NCT01624116

Completed 161 enrolled Services Hospital, Lahore
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Type 2 diabetic patients who fast during Ramadan experience swings in glycaemic control between hypoglycaemic troughs and hyperglycaemic spikes. Hence, the dual challenge in fasting diabetics is to identify which treatment modality leads to the most stable blood glucose levels during a fast and how to smooth out these excursions and reduce risks of fast to a minimum.

Timeline

Start
2011-08
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acarbose Unknown 50 mg
Comparator Glimepride Unknown 1 mg
Comparator Metformin Small molecule 500 mg
Comparator Metformin Small molecule
Comparator Sitagliptin Small molecule 50 mg